The FDA is obviously very interested since they have been monitoring the trial closely enough to want some questions answered.
The US government is very interested since they gave the company grant money.
No one wants this disease to make the leap out of Africa. Everyone wants the disease stopped.
The reason I put my toe in the water here is I expect a rush on this stock if Ebola enters the EU. TKMR has the best chance at a cure at the moment based on animal trials. Let's hope they get that phase I trial back on track soon. The world needs to find out whether or not this works on humans as it does in animals.
In Reply to 'nanopatent' If Ebola was in LA the FDA MIGHT be interested.
News 
Market Data 
Discover 
